2023 annual financial data
Addex Therapeutics 2023 Operating margin
Direct answer
Operating margin was -139.06%.
Operating income was -2,242,967 CHF and net income was -10,556,227 CHF.
Operating cash flow was -7,992,411 CHF.
Get free Addex Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,612,953 CHF
- Operating income
- -2,242,967 CHF
- Net income
- -10,556,227 CHF
- Operating cash flow
- -7,992,411 CHF